Powered by: Motilal Oswal
2025-12-09 11:15:34 am | Source: Accord Fintech
Aayush Wellness touches the roof on launching Immunity Booster Tablets
Aayush Wellness touches the roof on launching Immunity Booster Tablets

Aayush Wellness is currently trading at its upper circuit limit of Rs 32.23, up by 1.53 points or 4.98% from its previous closing of Rs 30.70 on the BSE.

The scrip opened at Rs 32.23 and has touched a high and low of Rs 32.23 and Rs 32.23 respectively. So far 118723 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs 267.30 on 18-Jul-2025 and a 52 week low of Rs 30.70 on 08-Dec-2025.

Last one week high and low of the scrip stood at Rs 32.23 and Rs 30.70 respectively. The current market cap of the company is Rs. 156.87 crore.

The Non-Institutions held 100.00% stake in the company.

Aayush Wellness has expanded its wellness portfolio with the launch of Immunity Booster Tablets, tapping into India’s rapidly growing $18 billion nutraceutical market. This strategic launch comes at a time when sedentary lifestyles, poor dietary choices, chronic stress, and seasonal changes have significantly weakened the immune resilience of millions. Designed to address this urgent need, the tablets offer a daily solution for strengthening the body's natural defense system in today’s fast-paced and health vulnerable environment.

In India, almost 38% of the population consumes an Unhealthy Diet, driven by urban lifestyles, lack of nutrition awareness, and economic constraints that make processed and high-calorie foods more accessible than minerals and nutrient-rich meals. Formulated with a potent blend of traditional and science-backed ingredients, Aayush Wellness’ Immunity Booster Tablets are designed to fortify the body’s natural defense system and promote daily resilience.

Aayush Wellness is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here